Concorde Asset Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.78M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$9.5M |
| 3 |
FT Vest Fund of Buffer ETFs
BUFR
|
+$6.83M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$6.47M |
| 5 |
First Trust NASDAQ Technology Dividend Index Fund
TDIV
|
+$6.21M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust Rising Dividend Achievers ETF
RDVY
|
+$5.82M |
| 2 |
iShares US Medical Devices ETF
IHI
|
+$4.21M |
| 3 |
Edison International
EIX
|
+$2.72M |
| 4 |
First Trust Utilities AlphaDEX Fund
FXU
|
+$2.51M |
| 5 |
FT Vest S&P 500 Dividend Aristocrats Target Income ETF
KNG
|
+$2.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.91% |
| 2 | Consumer Discretionary | 3.27% |
| 3 | Healthcare | 3% |
| 4 | Financials | 2.67% |
| 5 | Communication Services | 2.09% |
Similar funds
Concorde Asset Management's Q4 2023 Portfolio in Review
As of Q4 2023, Concorde Asset Management held 175 positions worth $147M, up 32% from $111M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Concorde Asset Management deployed $33.1M of net new capital in Q4 2023, opening 34 new positions and adding to 63 existing holdings. Its largest new stake was First Trust Enhanced Short Maturity ETF: 31,656 shares worth $1.89M.
By sector, the portfolio is most concentrated in Technology at 7.9% of assets, down from 9% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was First Trust Rising Dividend Achievers ETF, an estimated $5.82M trimmed.
- Concorde Asset Management's largest Q4 2023 buy was First Trust Enhanced Short Maturity ETF: 31,656 shares worth $1.89M.
- Concorde Asset Management added most to iShares Core S&P 500 ETF in Q4 2023, an estimated $9.78M increase.
- Concorde Asset Management's biggest Q4 2023 reduction was First Trust Rising Dividend Achievers ETF, cutting an estimated $5.82M.
- Concorde Asset Management fully exited iShares US Medical Devices ETF in Q4 2023, selling an estimated $4.21M.
- Concorde Asset Management's ten largest holdings make up 52% of its $147M portfolio in Q4 2023.
- Concorde Asset Management opened 34 new positions and closed 13 in Q4 2023.
- Concorde Asset Management's portfolio value rose 32% quarter-over-quarter to $147M.
Based on Concorde Asset Management's 13F filing for Q4 2023, filed 15 Feb 2024.